US 8,050,769 B2Grant

System and methods for determining nerve proximity, direction, and pathology during surgery

Issue Date:2011-11-01

•27 Claims

•16 Drawing Sheets

Abstract

The present invention involves systems and methods for determining nerve proximity, nerve direction, and pathology relative to a surgical instrument based on an identified relationship between neuromuscular responses and the stimulation signal that caused the neuromuscular responses.

Metadata

Assignee

NuVasive, Inc.

Inventors

James Gharib
Norbert F. Kaula
Jeffrey Blewett
Allen Farquhar

Application Information

Application Number:US 12/434,303

Filing Date:2009-05-01

Priority Date:2002-07-11

Art Unit:3762

Classifications

IPC:

A61B5/05

Patent Drawings (16 sheets)

Description

Cross-References to Related Applications

[0001] This application is a continuation of U.S. patent application Ser. No. 10/754,899 filed by Gharib et al. on Jan. 9, 2004 (the contents being incorporated herein by reference), which is a continuation of PCT Patent Application Ser. No. PCT/US02/22247 filed on Jul. 11, 2002 and published as WO03/005887 (the contents being incorporated herein by reference).

Background of the Invention

[0002] I. Field of the Invention

[0003] This invention relates to nerve monitoring systems and to nerve muscle monitoring systems, and more particularly to systems and methods for determining nerve proximity, nerve direction, and pathology during surgery.

[0004] II. Description of Related Art

[0005] Systems and methods exist for monitoring nerves and nerve muscles. One such system determines when a needle is approaching a nerve. The system applies a current to the needle to evoke a muscular response. The muscular response is visually monitored, typically as a shake or “twitch.” When such a muscular response is observed by the user, the needle is considered to be near the nerve coupled to the responsive muscle. These systems require the user to observe the muscular response (to determine that the needle has approached the nerve). This may be difficult depending on the competing tasks of the user. In addition, when general anesthesia is used during a procedure, muscular response may be suppressed, limiting the ability of a user to detect the response.

[0006] While generally effective (although crude) in determining nerve proximity, such existing systems are incapable of determining the direction of the nerve to the needle or instrument passing through tissue or passing by the nerves. This can be disadvantageous in that, while the surgeon may appreciate that a nerve is in the general proximity of the instrument, the inability to determine the direction of the nerve relative to the instrument can lead to guess work by the surgeon in advancing the instrument and thereby raise the specter of inadvertent contact with, and possible damage to, the nerve.

[0007] Another nerve-related issue in existing surgical applications involves the use of nerve retractors. A typical nerve retractor serves to pull or otherwise maintain the nerve outside the area of surgery, thereby protecting the nerve from inadvertent damage or contact by the “active” instrumentation used to perform the actual surgery. While generally advantageous in protecting the nerve, it has been observed that such retraction can cause nerve function to become impaired or otherwise pathologic over time due to the retraction. In certain surgical applications, such as spinal surgery, it is not possible to determine if such retraction is hurting or damaging the retracted nerve until after the surgery (generally referred to as a change in “nerve health” or “nerve status”). There are also no known techniques or systems for assessing whether a given procedure is having a beneficial effect on a nerve or nerve root known to be pathologic (that is, impaired or otherwise unhealthy).

[0008] Based on the foregoing, a need exists for a better system and method that can determine the proximity of a surgical instrument (including but not limited to a needle, catheter, cannula, probe, or any other device capable of traversing through tissue or passing near nerves or nerve structures) to a nerve or group of nerves during surgery. A need also exists for a system and method for determining the direction of the nerve relative to the surgical instrument. A still further need exists for a manner of monitoring nerve health or status during surgical procedures.

[0009] The present invention is directed at eliminating, or at least reducing the effects of, the above-described problems with the prior art, as well as addressing the above-identified needs.

Summary of the Invention

[0010] The present invention includes a system and related methods for determining nerve proximity and nerve direction to surgical instruments employed in accessing a surgical target site, as well as monitoring the status or health (pathology) of a nerve or nerve root during surgical procedures.

[0011] According to a broad aspect, the present invention includes a surgical system, comprising a control unit and a surgical instrument. The control unit has at least one of computer programming software, firmware and hardware capable of delivering a stimulation signal, receiving and processing neuromuscular responses due to the stimulation signal, and identifying a relationship between the neuromuscular response and the stimulation signal. The surgical instrument has at least one stimulation electrode electrically coupled to said control unit for transmitting the stimulation signal, wherein said control unit is capable of determining at least one of nerve proximity, nerve direction, and nerve pathology relative to the surgical instrument based on the identified relationship between the neuromuscular response and the stimulation signal.

[0012] In a further embodiment of the surgical system of the present invention, the control unit is further equipped to communicate at least one of alpha-numeric and graphical information to a user regarding at least one of nerve proximity, nerve direction, and nerve pathology.

[0013] In a further embodiment of the surgical system of the present invention, the surgical instrument may comprise at least one of a device for maintaining contact with a nerve during surgery, a device for accessing a surgical target site, and a device for testing screw placement integrity.

[0014] In a further embodiment of the surgical system of the present invention, the surgical instrument comprises a nerve root retractor and wherein the control unit determines nerve pathology based on the identified relationship between the neuromuscular response and the stimulation signal.

[0015] In a further embodiment of the surgical system of the present invention, the surgical instrument comprises a dilating instrument and wherein the control unit determines at least one of proximity and direction between a nerve and the instrument based on the identified relationship between the neuromuscular response and the stimulation signal.

[0016] In a further embodiment of the surgical system of the present invention, the dilating instrument comprises at least one of a K-wire, an obturator, a dilating cannula, and a working cannula.

[0017] In a further embodiment of the surgical system of the present invention, the surgical instrument comprises a screw test probe and wherein the control unit determines the proximity between the screw test probe and an exiting spinal nerve root to assess whether a medial wall of a pedicle has been breached by at least one of hole formation and screw placement.

Brief Description of the Drawings

[0018] FIG. 1 is a perspective view of a surgical system 10 capable of determining, among other things, nerve proximity, direction, and pathology according to one aspect of the present invention;

[0019] FIG. 2 is a block diagram of the surgical system 10 shown in FIG. 1;

[0020] FIG. 3 is a graph illustrating a plot of the neuromuscular response (EMG) of a given myotome over time based on a current stimulation pulse (similar to that shown in FIG. 4) applied to a nerve bundle coupled to the given myotome;

[0021] FIG. 4 is a graph illustrating a plot of a stimulation current pulse capable of producing a neuromuscular response (EMG) of the type shown in FIG. 3;

[0022] FIG. 5 is a graph illustrating a plot of peak-to-peak voltage (Vpp) for each given stimulation current level (I_Stim) forming a stimulation current pulse train according to the present invention (otherwise known as a “recruitment curve”);

[0023] FIG. 6 is a graph illustrating a plot of a neuromuscular response (EMG) over time (in response to a stimulus current pulse) showing the manner in which maximum voltage (V_Max) and minimum voltage (V_Min) occur at times T1 and T2, respectively;

[0024] FIG. 7 is an exemplary touch-screen display according to the present invention, capable of communicating a host of alpha-numeric and/or graphical information to a user and receiving information and/or instructions from the user during the operation of the surgical system 10 of FIG. 1;

[0025] FIGS. 8A-8E are graphs illustrating a rapid current threshold-hunting algorithm according to one embodiment of the present invention;

[0026] FIG. 9 is a series of graphs illustrating a multi-channel rapid current threshold-hunting algorithm according to one embodiment of the present invention;

[0027] FIG. 10 is a graph illustrating a T1, T2 artifact rejection technique according to one embodiment of the present invention via the use of histograms;

[0028] FIG. 11 is a graph illustrating the proportion of stimulations versus the number of stimulations employed in the T1, T2 artifact rejection technique according to the present invention;

[0029] FIG. 12 is an illustrating (graphical and schematic) of a method of automatically determining the maximum frequency (F_Max) of the stimulation current pulses according to one embodiment of the present invention;

[0030] FIG. 13 is a graph illustrating a method of determining the direction of a nerve (denoted as an “octagon”) relative to an instrument having four (4) orthogonally disposed stimulation electrodes (denoted by the “circles”) according to one embodiment of the present invention;

[0031] FIG. 14 is a graph illustrating recruitment curves for a generally healthy nerve (denoted “A”) and a generally unhealthy nerve (denoted “B”) according to the nerve pathology determination method of the present invention;

[0032] FIG. 15 is flow chart illustrating an alternate method of determining the hanging point of a recruitment curve according to an embodiment of the present invention; and

[0033] FIG. 16 is a graph illustrating a simulated recruitment curve generated by a “virtual patient” device and method according to the present invention.

Description of the Specific Embodiments

[0034] Illustrative embodiments of the invention are described below. In the interest of clarity, not all features of an actual implementation are described in this specification. It will of course be appreciated that in the development of any such actual embodiment, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which will vary from one implementation to another. Moreover, it will be appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking for those of ordinary skill in the art having the benefit of this disclosure. The systems disclosed herein boast a variety of inventive features and components that warrant patent protection, both individually and in combination.

[0035] FIG. 1 illustrates, by way of example only, a surgical system 10 capable of employing the nerve proximity, nerve direction, and nerve pathology assessments according to the present invention. As will be explained in greater detail below, the surgical system 10 is capable of providing safe and reproducible access to any number of surgical target sites, and well as monitoring changes in nerve pathology (health or status) during surgical procedures. It is expressly noted that, although described herein largely in terms of use in spinal surgery, the surgical system 10 and related methods of the present invention are suitable for use in any number of additional surgical procedures wherein tissue having significant neural structures must be passed through (or near) in order to establish an operative corridor, or where neural structures are retracted.

[0036] The surgical system 10 includes a control unit 12, a patient module 14, an EMG harness 16 and return electrode 18 coupled to the patient module 14, and a host of surgical accessories 20 capable of being coupled to the patient module 14 via one or more accessory cables 22. The surgical accessories 20 may include, but are not necessarily limited to, surgical access components (such as a K-wire 24, one or more dilating cannula 26, and a working cannula 28), neural pathology monitoring devices (such as nerve root retractor 30), and devices for performing pedicle screw test (such as screw test probe 32). A block diagram of the surgical system 10 is shown in FIG. 2, the operation of which is readily apparent in view of the following description.

[0037] The control unit 12 includes a touch screen display 36 and a base 38. The touch screen display 36 is preferably equipped with a graphical user interface (GUI) capable of communicating information to the user and receiving instructions from the user. The base 38 contains computer hardware and software that commands the stimulation sources, receives digitized signals and other information from the patient module 14, and processes the EMG responses to extract characteristic information for each muscle group, and displays the processed data to the operator via the display 36. The primary functions of the software within the control unit 12 include receiving user commands via the touch screen display 36, activating stimulation in the requested mode (nerve proximity, nerve detection, nerve pathology, screw test), processing signal data according to defined algorithms (described below), displaying received parameters and processed data, and monitoring system status and report fault conditions.

[0038] The patient module 14 is connected via a serial cable 40 to the control unit 12, and contains the electrical connections to all electrodes, signal conditioning circuitry, stimulator drive and steering circuitry, and a digital communications interface to the control unit 12. In use, the control unit 12 is situated outside but close to the surgical field (such as on a cart adjacent the operating table) such that the display 36 is directed towards the surgeon for easy visualization. The patient module 14 should be located between the patient's legs, or may be affixed to the end of the operating table at mid-leg level using a bedrail clamp. The position selected should be such that the EMG leads can reach their farthest desired location without tension during the surgical procedure.

[0039] In a significant aspect of the present invention, the information displayed to the user on display 36 may include, but is not necessarily limited to, alpha-numeric and/or graphical information regarding nerve proximity, nerve direction, nerve pathology, stimulation level, myotome/EMG levels, screw testing, advance or hold instructions, and the instrument in use. In one embodiment (set forth by way of example only) the display includes the following components as set forth in Table 1:

[0040]

TABLE 1

Screen
Component	Description

Menu/	The mode label may include the surgical accessory attached,
Status Bar	such as the surgical access components (K-Wire, Dilating
	Cannula,Working Cannula), nerve pathology monitoring
	device (Nerve Root Retractor), and/or screw test device
	(Screw Test Probe) depending on which is attached.
Spine	An image of a human body/skeleton showing the electrode
Image	placement on the body, with labeled channel number
	tabs on each side (1-4 on left and right). Left and Right
	labels will show the patient orientation. The Channel
	number tabs may be highlighted or colored depending
	on the specificfunction being performed.
Display	Shows procedure-specific information.
Area
Myotome	A label to indicate the Myotome name and corresponding
& Level	Spinal Level(s) associated with the channel of interest.
Names
Advance/	When in the Detection mode, an indication of “Advance”
Hold	will show when it is safe to move the cannula forward
	(such as when the minimum stimulation current
	threshold I_Thresh(described below) is greater than a
	predetermined value, indicating a safe distance to the
	nerve) and “Hold” will show when it is unsafe to advance
	the cannula (such as when the minimum stimulation
	current threshold I_Thresh(described below) is less than a
	predetermined value, indicating that the nerve is relatively
	close to the cannula) and during proximity calculations.
Function	Indicates which function is currently active (Direction,
	Detection, Pathology Monitoring, Screw Test).
Dilator	A colored circle to indicate the inner diameter of the
In Use	cannula, with the numeric size. If cannula is detached,
	no indicator is displayed.

[0041] The surgical system 10 accomplishes safe and reproducible access to a surgical target site by detecting the existence of (and optionally the distance and/or direction to) neural structures before, during, and after the establishment of an operative corridor through (or near) any of a variety of tissues having such neural structures which, if contacted or impinged, may otherwise result in neural impairment for the patient. The surgical system 10 does so by electrically stimulating nerves via one or more stimulation electrodes at the distal end of the surgical access components 24-28 while monitoring the EMG responses of the muscle groups innervated by the nerves. In a preferred embodiment, this is accomplished via 8 pairs of EMG electrodes 34 placed on the skin over the major muscle groups on the legs (four per side), an anode electrode 35 providing a return path for the stimulation current, and a common electrode 37 providing a ground reference to pre-amplifiers in the patient module 14. By way of example, the placement of EMG electrodes 34 may be undertaken according to the manner shown in Table 2 below for spinal surgery:

[0042]

TABLE 2

	Channel
Color	ID	Myotome	Nerve	Spinal Level

Red	Right 1	Right Vastus Medialis	Femoral	L2, L3, L4
Orange	Right 2	Right Tibialis Anterior	Peroneal	L4, L5
Yellow	Right 3	Right Biceps Femoris	Sciatic	L5, S1, S2
Green	Right 4	Right Gastroc. Medial	Post Tibialis	S1, S2
Blue	Left 1	Left Vastus Medialis	Femoral	L2, L3, L4
Violet	Left 2	Left Tibialis Anterior	Peroneal	L4, L5
Gray	Left 3	Left Biceps Femoris	Sciatic	L5, S1, S2
White	Left 4	Left Gastroc. Medial	Post Tibialis	S1, S2

[0043] Although not shown, it will be appreciated that any of a variety of electrodes can be employed, including but not limited to needle electrodes. The EMG responses provide a quantitative measure of the nerve depolarization caused by the electrical stimulus. Analysis of the EMG responses is then used to determine the proximity and direction of the nerve to the stimulation electrode, as will be described with particularity below.

[0044] The surgical access components 24-28 are designed to bluntly dissect the tissue between the patient's skin and the surgical target site. An initial dilating cannula 26 is advanced towards the target site, preferably after having been aligned using any number of commercially available surgical guide frames. An obturator (not shown) may be included inside the initial dilator 26 and may similarly be equipped with one or more stimulating electrodes. Once the proper location is achieved, the obturator (not shown) may be removed and the K-wire 24 inserted down the center of the initial dilating cannula 26 and docked to the given surgical target site, such as the annulus of an intervertebral disc. Cannulae of increasing diameter are then guided over the previously installed cannula 26 until the desired lumen is installed. By way of example only, the dilating cannulae 26 may range in diameter from 6 mm to 30 mm. In one embodiment, each cannula 26 has four orthogonal stimulating electrodes at the tip to allow detection and direction evaluation, as will be described below. The working cannula 28 is installed over the last dilating cannula 26 and then all the dilating cannulae 26 are removed from inside the inner lumen of the working cannula 28 to establish the operative corridor therethrough. A stimulator driver 42 is provided to electrically couple the particular surgical access component 24-28 to the patient module 14 (via accessory cable 22). In a preferred embodiment, the stimulator driver 42 includes one or more buttons for selectively activating the stimulation current and/or directing it to a particular surgical access component.

[0045] The surgical system 10 accomplishes neural pathology monitoring by electrically stimulating a retracted nerve root via one or more stimulation electrodes at the distal end of the nerve root retractor 30 while monitoring the EMG responses of the muscle group innervated by the particular nerve. The EMG responses provide a quantitative measure of the nerve depolarization caused by the electrical stimulus. Analysis of the EMG responses may then be used to assess the degree to which retraction of a nerve or neural structure affects the nerve function over time, as will be described with greater particularity below. One advantage of such monitoring, by way of example only, is that the conduction of the nerve may be monitored during the procedure to determine whether the neurophysiology and/or function of the nerve changes (for the better or worse) as the result of the particular surgical procedure. For example, it may be observed that the nerve conduction increases as the result of the operation, indicating that the previously inhibited nerve has been positively affected by the operation. The nerve root retractor 30 may comprise any number of suitable devices capable of maintaining contact with a nerve or nerve root. The nerve root retractor 30 may be dimensioned in any number of different fashions, including having a generally curved distal region (shown as a side view in FIG. 1 to illustrate the concave region where the nerve will be positioned while retracted), and of sufficient dimension (width and/or length) and rigidity to maintain the retracted nerve in a desired position during surgery. The nerve root retractor 30 may also be equipped with a handle 31 having one or more buttons for selectively applying the electrical stimulation to the stimulation electrode(s) at the end of the nerve root retractor 30. In one embodiment, the nerve root retractor 30 is disposable and the handle 31 is reusable and autoclavable.

[0046] The surgical system 10 can also be employed to perform screw test assessments via the use of screw test probe 32. The screw test probe 32 is used to test the integrity of pedicle holes (after formation) and/or screws (after introduction). The screw test probe 32 includes a handle 44 and a probe member 46 having a generally ball-tipped end 48. The handle 44 may be equipped with one or more buttons for selectively applying the electrical stimulation to the ball-tipped end 48 at the end of the probe member 46. The ball tip 48 of the screw test probe 32 is placed in the screw hole prior to screw insertion or placed on the installed screw head. If the pedicle wall has been breached by the screw or tap, the stimulation current will pass through to the adjacent nerve roots and they will depolarize at a lower stimulation current.

[0047] Upon pressing the button on the screw test handle 44, the software will execute an algorithm that results in all channel tabs being color-coded to indicate the detection status of the corresponding nerve. The channel with the “worst” (lowest) level will be highlighted (enlarged) and that myotome name will be displayed, as well as graphically depicted on the spine diagram. A vertical bar chart will also be shown, to depict the stimulation current required for nerve depolarization in mA for the selected channel. The screw test algorithm preferably determines the depolarization (threshold) current for all 8 EMG channels. The surgeon may also set a baseline threshold current by stimulating a nerve root directly with the screw test probe 32. The surgeon may choose to display the screw test threshold current relative to this baseline. The handle 44 may be equipped with a mechanism (via hardware and/or software) to identify itself to the system when it is attached. In one embodiment, the probe member 46 is disposable and the handle 44 is reusable and autoclavable.

[0048] An audio pick-up (not shown) may also be provided as an optional feature according to the present invention. In some cases, when a nerve is stretched or compressed, it will emit a burst or train of spontaneous nerve activity. The audio pick-up is capable of transmitting sounds representative of such activity such that the surgeon can monitor this response on audio to help him determine if there has been stress to the nerve.

[0049] Analysis of the EMG responses according to the present invention will now be described. The nerve proximity, nerve direction, and nerve pathology features of the present invention are based on assessing the evoked response of the various muscle myotomes monitored by the surgical system 10. This is best shown in FIGS. 3-4, wherein FIG. 3 illustrates the evoked response (EMG) of a monitored myotome to the stimulation current pulse shown in FIG. 4. The EMG response can be characterized by a peak to peak voltage of V_pp=V_max−V_min. The stimulation current is preferably DC coupled and comprised of monophasic pulses of 200 microsecond duration with frequency and amplitude that is adjusted by the software. For each nerve and myotome there is a characteristic delay from the stimulation current pulse to the EMG response.

[0050] As shown in FIG. 5, there is a threshold stimulation current required to depolarize the main nerve trunk. Below this threshold, current stimulation does not evoke a significant V_ppresponse. Once the stimulation threshold is reached, the evoked response is reproducible and increases with increasing stimulation, as shown in FIG. 5. This is known as a “recruitment curve.” In one embodiment, a significant Vpp is defined to be a minimum of 100 uV. The lowest stimulation current that evoked this threshold voltage is called I_thresh. I_threshdecreases as the stimulation electrode approaches the nerve. This value is useful to surgeons because it provides a relative indication of distance (proximity) from the electrode to the nerve.

[0051] As shown in FIG. 6, for each nerve/myotome combination there is a characteristic delay from the stimulation current pulse to the EMG response. For each stimulation current pulse, the time from the current pulse to the first max/min is T₁and to the second max/min is T₂. The first phase of the pulse may be positive or negative. As will be described below, the values of T₁, T₂are each compiled into a histogram with bins as wide as the sampling rate. New values of T₁, T₂are acquired with each stimulation and the histograms are continuously updated. The value of T₁and T₂used is the center value of the largest bin in the histogram. The values of T₁, T₂are continuously updated as the histograms change. Initially Vpp is acquired using a window that contains the entire EMG response. After 20 samples, the use of T₁, T₂windows is phased in over a period of 200 samples. Vmax and Vmin are then acquired only during windows centered around T₁, T₂with widths of, by way of example only, 5 msec. This method of acquiring V_ppis advantageous in that it automatically performs artifact rejection (as will be described in greater detail below).

[0052] As will be explained in greater detail below, the use of the “recruitment curve” according to the present invention is advantageous in that it provides a great amount of useful data from which to make various assessments (including, but not limited to, nerve detection, nerve direction, and nerve pathology monitoring). Moreover, it provides the ability to present simplified yet meaningful data to the user, as opposed to the actual EMG waveforms that are displayed to the users in traditional EMG systems. Due to the complexity in interpreting EMG waveforms, such prior art systems typically require an additional person specifically trained in such matters. This, in turn, can be disadvantageous in that it translates into extra expense (having yet another highly trained person in attendance) and oftentimes presents scheduling challenges because most hospitals do not retain such personnel. To account for the possibility that certain individuals will want to see the actual EMG waveforms, the surgical system 10 includes an Evoked Potentials display that shows the voltage waveform for all 8 EMG channels in real time. It shows the response of each monitored myotome to a current stimulation pulse. The display is updated each time there is a stimulation pulse. The Evoked Potentials display may be accessed during Detection, Direction, or Nerve Pathology Monitoring.

[0053] Nerve Detection (Proximity)

[0054] The Nerve Detection function of the present invention is used to detect a nerve with a stimulation electrode (i.e. those found on the surgical access components 24-28) and to give the user a relative indication of the proximity of the nerve to the electrode are advanced toward the surgical target site. A method of nerve proximity detection according one embodiment of the present invention is summarized as follows: (1) stimulation current pulses are emitted from the electrode with a fixed pulse width of 200 μs and a variable amplitude; (2) the EMG response of the associated muscle group is measured; (3) the Vpp of the EMG response is determined using T1, T2, and Fmax (NB: before T2 is determined, a constant Fsafe is used for Fmax); (4) a rapid hunting detection algorithm is used to determine I_Threshfor a known Vthresh minimum; (5) the value of I_tis displayed to the user as a relative indication of the proximity of the nerve, wherein the I_Threshis expected to decrease as the probe gets closer to the nerve. A detailed description of the algorithms associated with the foregoing steps will follow after a general description of the manner in which this proximity information is communicated to the user.

[0055] The Detection Function displays the value of I_threshto the surgeon along with a color code so that the surgeon may use this information to avoid contact with neural tissues. This is shown generally in FIG. 7, which illustrates an exemplary screen display according to the present invention. Detection display is based on the amplitude of the current (I_thresh) required to evoke an EMG Vpp response greater than V_thresh(nominally 100 uV). According to one embodiment, if I_threshis <=4 mA red is displayed, the absolute value of I_threshis displayed. If 4 mA<I_thresh<10 mA yellow is displayed. If I_thresh>=10 mA green is displayed. Normally, I_threshis only displayed when it is in the red range. However, the surgeon has the option of displaying I_threshfor all three ranges (red, yellow, green). The maximum stimulation current is preferably set by the user and is preferably within the range of between 0-100 mA. Detection is performed on all 4 channels of the selected side. EMG channels on the opposite side are not used. The first dilator 26 may use an obturator having an electrode for stimulation. In one embodiment, all subsequent dilators 26 and the working cannula 28 use four electrodes for stimulation. The lowest value of I_threshfrom the 4 electrodes is used for display. There is an “Advance/Hold” display that tells the surgeon when the calculations are finished and he may continue to advance the instrument.

[0056] The threshold-hunting algorithm employs a series of monopolar stimulations to determine the stimulation current threshold for each EMG channel that is in scope. The nerve is stimulated using current pulses with amplitude of Istim. The muscle groups respond with an evoked potential that has a peak to peak voltage of Vpp. The object of this algorithm is to quickly find I_Thresh. This is the minimum Istim that results in a Vpp that is greater than a known threshold voltage Vthresh. The value of Istim is adjusted by a bracketing method as follows. The first bracket is 0.2 mA and 0.3 mA. If the Vpp corresponding to both of these stimulation currents is lower than Vthresh, then the bracket size is doubled to 0.2 mA and 0.4 mA. This exponential doubling of the bracket size continues until the upper end of the bracket results in a Vpp that is above Vthresh. The size of the brackets is then reduced by a bisection method. A current stimulation value at the midpoint of the bracket is used and if this results in a Vpp that is above Vthresh, then the lower half becomes the new bracket. Likewise, if the midpoint Vpp is below Vthresh then the upper half becomes the new bracket. This bisection method is used until the bracket size has been reduced to Ires mA. I_Threshis the value of Istim that is the higher end of the bracket.

[0057] More specifically, with reference to FIGS. 8A-8E, the threshold hunting will support three states: bracketing, bisection, and monitoring. A stimulation current bracket is a range of stimulation currents that bracket the stimulation current threshold I_Thresh. The upper and/or lower boundaries of a bracket may be indeterminate. The width of a bracket is the upper boundary value minus the lower boundary value. If the stimulation current threshold I_Threshof a channel exceeds the maximum stimulation current, that threshold is considered out-of-range. During the bracketing state, threshold hunting will employ the method below to select stimulation currents and identify stimulation current brackets for each EMG channel in scope.

[0058] The method for finding the minimum stimulation current uses the methods of bracketing and bisection. The “root” is identified for a function that has the value −1 for stimulation currents that do not evoke adequate response; the function has the value +1 for stimulation currents that evoke a response. The root occurs when the function jumps from −1 to +1 as stimulation current is increased: the function never has the value of precisely zero. The root will not be known precisely, but only with some level of accuracy. The root is found by identifying a range that must contain the root. The upper bound of this range is the lowest stimulation current I_Threshwhere the function returns the value +1, i.e. the minimum stimulation current that evokes response.

[0059] The proximity function begins by adjusting the stimulation current until the root is bracketed (FIG. 8B). The initial bracketing range may be provided in any number of suitable ranges. In one embodiment, the initial bracketing range is 0.2 to 0.3 mA. If the upper stimulation current does not evoke a response, the upper end of the range should be increased. The range scale factor is 2. The stimulation current should never be increased by more than 10 mA in one iteration. The stimulation current should never exceed the programmed maximum stimulation current. For each stimulation, the algorithm will examine the response of each active channel to determine whether it falls within that bracket. Once the stimulation current threshold of each channel has been bracketed, the algorithm transitions to the bisection state.

[0060] During the bisection state (FIGS. 8C and 8D), threshold hunting will employ the method described below to select stimulation currents and narrow the bracket to a width of 0.1 mA for each EMG channel with an in-range threshold. After the minimum stimulation current has been bracketed (FIG. 8B), the range containing the root is refined until the root is known with a specified accuracy. The bisection method is used to refine the range containing the root. In one embodiment, the root should be found to a precision of 0.1 mA. During the bisection method, the stimulation current at the midpoint of the bracket is used. If the stimulation evokes a response, the bracket shrinks to the lower half of the previous range. If the stimulation fails to evoke a response, the bracket shrinks to the upper half of the previous range. The proximity algorithm is locked on the electrode position when the response threshold is bracketed by stimulation currents separated by 0.1 mA. The process is repeated for each of the active channels until all thresholds are precisely known. At that time, the algorithm enters the monitoring state.

[0061] During the monitoring state (FIG. 8E), threshold hunting will employ the method described below to select stimulation currents and identify whether stimulation current thresholds are changing. In the monitoring state, the stimulation current level is decremented or incremented by 0.1 mA, depending on the response of a specific channel. If the threshold has not changed then the lower end of the bracket should not evoke a response, while the upper end of the bracket should. If either of these conditions fail, the bracket is adjusted accordingly. The process is repeated for each of the active channels to continue to assure that each threshold is bracketed. If stimulations fail to evoke the expected response three times in a row, then the algorithm transitions back to the bracketing state in order to reestablish the bracket.

[0062] When it is necessary to determine the stimulation current thresholds (I_t) for more than one channel, they will be obtained by time-multiplexing the threshold-hunting algorithm as shown in FIG. 9. During the bracketing state, the algorithm will start with a stimulation current bracket of 0.2 mA and increase the size of the bracket exponentially. With each bracket, the algorithm will measure the Vpp of all channels to determine which bracket they fall into. After this first pass, the algorithm will know which exponential bracket contains the I_tfor each channel. Next, during the bisection state, the algorithm will start with the lowest exponential bracket that contains an I_tand bisect it until I_tis found within 0.1 mA. If there are more than one I_twithin an exponential bracket, they will be separated out during the bisection process, and the one with the lowest value will be found first. During the monitoring state, the algorithm will monitor the upper and lower boundries of the brackets for each I_t, starting with the lowest. If the I_tfor one or more channels is not found in it's bracket, then the algorithm goes back to the bracketing state to re-establish the bracket for those channels.

[0063] The method of performing automatic artifact rejection according to the present invention will now be described. As noted above, acquiring V_ppaccording to the present invention (based on T1, T2 shown in FIG. 6) is advantageous in that, among other reasons, it automatically performs artifact rejection. The nerve is stimulated using a series of current pulses above the stimulation threshold. The muscle groups respond with an evoked potential that has a peak to peak voltage of Vpp. For each EMG response pulse, T1 is the time is measured from the stimulus pulse to the first extremum (Vmax or Vmin). T2 is the time measured from the current pulse to the second extremum (Vmax or Vmin). The values of T1 and T2 are each compiled into a histogram with Tbin msec bin widths. The value of T1 and T2 used for artifact rejection is the center value of the largest bin in the histogram. To reject artifacts when acquiring the EMG response, Vmax and Vmin are acquired only during windows that are T1±Twin and T2±Twin. Again, with reference to FIG. 6, Vpp is Vmax−Vmin.

[0064] The method of automatic artifact rejection is further explained with reference to FIG. 10. While the threshold hunting algorithm is active, after each stimulation, the following steps are undertaken for each EMG sensor channel that is in scope: (1) the time sample values for the waveform maximum and minimum (after stimulus artifact rejection) will be placed into a histogram; (2) the histogram bin size will be the same granularity as the sampling period; (3) the histogram will be emptied each time the threshold hunting algorithm is activated; (4) the histogram will provide two peaks, or modes, defined as the two bins with the largest counts; (5) the first mode is defined as T1; the second mode is defined as T2; (6) a (possibly discontinuous) range of waveform samples will be identified; (7) for the first stimulation after the threshold hunting algorithm is activated, the range of samples will be the entire waveform; (8) after a specified number of stimulations, the range of samples will be limited to T1±0.5 ms and T2±0.5 ms; and (9) before the specified number of stimulations, either range may be used, subject to this restriction: the proportion of stimulations using the entire waveform will decrease from 100% to 0% (a sample of the curve governing this proportion is shown in FIG. 11). Peak-to-peak voltage (Vpp) will be measured either over the identified range of waveform samples. The specified number of stimulations will preferably be between 220 and 240.

[0065] According to another aspect of the present invention, the maximum frequency of the stimulation pulses is automatically obtained with reference to FIG. 12. After each stimulation, Fmax will be computed as: Fmax=1/(T2+Safety Margin) for the largest value of T2 from each of the active EMG channels. In one embodiment, the Safety Margin is 5 ms, although it is contemplated that this could be varied according to any number of suitable durations. Before the specified number of stimulations, the stimulations will be performed at intervals of 100-120 ms during the bracketing state, intervals of 200-240 ms during the bisection state, and intervals of 400-480 ms during the monitoring state. After the specified number of stimulations, the stimulations will be performed at the fastest interval practical (but no faster than Fmax) during the bracketing state, the fastest interval practical (but no faster than Fmax/2) during the bisection state, and the fastest interval practical (but no faster than Fmax/4) during the monitoring state. The maximum frequency used until F_maxis calculated is preferably 10 Hz, although slower stimulation frequencies may be used during some acquisition algorithms. The value of F_maxused is periodically updated to ensure that it is still appropriate. This feature is represented graphically, by way of example only, in FIG. 12. For physiological reasons, the maximum frequency for stimulation will be set on a per-patient basis. Readings will be taken from all myotomes and the one with the slowest frequency (highest T2) will be recorded.

[0066] Nerve Direction

[0067] Once a nerve is detected using the working cannula 28 or dilating cannulae 26, the surgeon may use the Direction Function to determine the angular direction to the nerve relative to a reference mark on the access components 24-28. This is also shown in FIG. 7 as the arrow A pointing to the direction of the nerve. This information helps the surgeon avoid the nerve as he or she advances the cannula. The direction from the cannula to a selected nerve is estimated using the 4 orthogonal electrodes on the tip of the dilating cannula 26 and working cannulae 28. These electrodes are preferably scanned in a monopolar configuration (that is, using each of the 4 electrodes as the stimulation source). The nerve's threshold current (I_thresh) is found for each of the electrodes by measuring the muscle evoked potential response Vpp and comparing it to a known threshold Vthresh. This algorithm is used to determine the direction from a stimulation electrode to a nerve.

[0068] As shown in FIG. 13, the four (4) electrodes are placed on the x and y axes of a two dimensional coordinate system at radius R from the origin. A vector is drawn from the origin along the axis corresponding to each electrode that has a length equal to I_Threshfor that electrode. The vector from the origin to a direction pointing toward the nerve is then computed. This algorithm employs the T1/T2 algorithm discussed above with reference to FIG. 6. Using the geometry shown in FIG. 10, the (x,y) coordinates of the nerve, taken as a single point, can be determined as a function of the distance from the nerve to each of four electrodes. This can be expressly mathematically as follows:

- [0069] Where the “circles” denote the position of the electrode respective to the origin or center of the cannula and the “octagon” denotes the position of a nerve, and d₁, d₂, d₃, and d₄denote the distance between the nerve and electrodes 1-4 respectively, it can be shown that:

[0070]

x = \frac{d_{1}^{2} - d_{3}^{2}}{- 4 R} and y = \frac{d_{2}^{2} - d_{4}^{2}}{- 4 R}

- [0071] Where R is the cannula radius, standardized to 1, since angles and not absolute values are measured.

[0072] After conversion from (x,y) to polar coordinates (r,θ), then θ is the angular direction to the nerve. This angular direction is then displayed to the user as shown in FIG. 7, by way of example only, as arrow A pointing towards the nerve. In this fashion, the surgeon can actively avoid the nerve, thereby increasing patient safety while accessing the surgical target site. The surgeon may select any one of the 4 channels available to perform the Direction Function. The surgeon should preferably not move or rotate the instrument while using the Direction Function, but rather should return to the Detection Function to continue advancing the instrument.

[0073] Insertion and advancement of the access instruments 24-28 should be performed at a rate sufficiently slow to allow the surgical system 10 to provide real-time indication of the presence of nerves that may lie in the path of the tip. To facilitate this, the threshold current I_Threshmay be displayed such that it will indicate when the computation is finished and the data is accurate. For example, when the detection information is up to date and the instrument such that it is now ready to be advanced by the surgeon, it is contemplated to have the color display show up as saturated to communicate this fact to the surgeon. During advancement of the instrument, if a channel's color range changes from green to yellow, advancement should proceed more slowly, with careful observation of the detection level. If the channel color stays yellow or turns green after further advancement, it is a possible indication that the instrument tip has passed, and is moving farther away from the nerve. If after further advancement, however, the channel color turns red, then it is a possible indication that the instrument tip has moved closer to a nerve. At this point the display will show the value of the stimulation current threshold in mA. Further advancement should be attempted only with extreme caution, while observing the threshold values, and only if the clinician deems it safe. If the clinician decides to advance the instrument tip further, an increase in threshold value (e.g. from 3 mA to 4 mA) may indicate the Instrument tip has safely passed the nerve. It may also be an indication that the instrument tip has encountered and is compressing the nerve. The latter may be detected by listening for sporadic outbursts, or “pops”, of nerve activity on the free running EMG audio output (as mentioned above). If, upon further advancement of the instrument, the alarm level decreases (e.g., from 4 mA to 3 mA), then it is very likely that the instrument tip is extremely close to the spinal nerve, and to avoid neural damage, extreme caution should be exercised during further manipulation of the Instrument. Under such circumstances, the decision to withdraw, reposition, or otherwise maneuver the instrument is at the sole discretion of the clinician based upon available information and experience. Further radiographic imaging may be deemed appropriate to establish the best course of action.

[0074] Nerve Pathology

[0075] As noted above, the surgical system 10 accomplishes neural pathology monitoring by electrically stimulating a retracted nerve root via one or more stimulation electrodes at the distal end of the nerve root retractor 30 while monitoring the EMG responses of the muscle group innervated by the particular nerve. FIG. 14 shows the differences between a healthy nerve (A) and a pathologic or unhealthy nerve (B). The inventors have found through experimentation that information regarding nerve pathology (or “health” of “status”) can be extracted from the recruitment curves generated according to the present invention (see, e.g., discussion accompanying FIGS. 3-5). In particular, it has been found that a health nerve or nerve bundle will produce a recruitment curve having a generally low threshold or “hanging point” (in terms of both the y-axis or Vpp value and the x-axis or I_Stimvalue), a linear region having a relatively steep slope, and a relatively high saturation region (similar to those shown on recruitment curve “A” in FIG. 14). On the contrary, a nerve or nerve bundle that is unhealthy or whose function is otherwise compromised or impaired (such as being impinged by spinal structures or by prolonged retraction) will produce recruitment curve having a generally higher threshold (again, in terms of both the y-axis or Vpp value and the x-axis or I_Stimvalue), a linear region of reduced slope, and a relatively low saturation region (similar to those shown on recruitment curve “B” in FIG. 14). By recognizing these characteristics, one can monitor nerve root being retracted during a procedure to determine if its pathology or health is affected (i.e. negatively) by such retraction. Moreover, one can monitor a nerve root that has already been deemed pathologic or unhealthy before the procedure (such as may be caused by being impinged by bony structures or a bulging annulus) to determine if its pathology or health is affected (i.e. positively) by the procedure.

[0076] The surgical system 10 and related methods have been described above according to one embodiment of the present invention. It will be readily appreciated that various modifications may be undertaken, or certain steps or algorithms omitted or substituted, without departing from the scope of the present invention. By way of example only, certain of these alternate embodiments or methods will be described below.

[0077] a. Hanging Point Detection Via Linear Regression

[0078] As opposed to identifying the stimulation current threshold (I_Thresh) based on a predetermined V_Thresh(such as described above and shown in FIG. 5), it is also within the scope of the present invention to determine I_Threshvia linear regression. This may be accomplished via, by way of example only, the linear regression technique disclosed in commonly owned and co-pending U.S. patent application Ser. No. 09/877,713, filed Jun. 8, 200 and entitled “Relative Nerve Movement and Status Detection System and Methods,” the entire contents of which is hereby expressly incorporated by reference as if set forth in this disclosure in its entirety.

[0079] b. Hanging Point Detection Via Dynamic Sweep Subtraction

[0080] With reference to FIG. 15, the hanging point or threshold may also be determined by the following dynamic sweep subtraction method. The nerve is stimulated in step 80 using current pulses that increase from I_Minto I_Max(as described above). The resulting the neuromuscular response (evoked EMG) for the associated muscles group is acquired in step 82. The peak-to-peak voltage (Vpp) is then extracted in step 84 for each current pulse according to the T1, T2 algorithm described above with reference to FIGS. 3-6. A first recruitment curve (S1) is then generated by plotting Vpp vs. I_Stimin step 86. The same nerve is then stimulated such that, in step 88, the peak-to-peak voltage (Vpp) may be extracted by subtracting the V_Maxfrom V_Minof each EMG response without the T1, T2 filters employed in step 84. A second recruitment curve (S2) is then generated in step 90 by plotting Vpp vs. I_Stim. The generation of both recruitment curves S1, S2 continues until the maximum stimulation current (I_Max) is reached (per the decision step 92). If I_Maxis not reached, the stimulation current I_Stimis incremented in step 94. If I_Maxis reached, then the first recruitment curve S1 is subtracted from the second recruitment curve S2 in step 96 to produce the curve “C” shown in step 98. By subtracting S1 from S2, the resulting curve “C” is actually the onset portion of the recruitment curve (that is, the portion before the threshold is reached) for that particular nerve. In this fashion, the last point in the curve “C” is the point with the greatest value of I_Stimand hence the hanging point.

[0081] c. Peripheral Nerve Pathology Monitoring

[0082] Similar to the nerve pathology monitoring scheme described above, the present invention also contemplates the use of one or more electrodes disposed along a portion or portions of an instrument (including, but not limited to, the access components 24-28 described above) for the purpose of monitoring the change, if any, in peripheral nerves during the course of the procedure. In particular, this may be accomplished by disposing one or more stimulation electrodes a certain distance from the distal end of the instrument such that, in use, they will likely come in contact with a peripheral nerve. For example, a mid-shaft stimulation electrode could be used to stimulate a peripheral nerve during the procedure. In any such configuration, a recruitment curve may be generated for the given peripheral nerve such that it can be assessed in the same fashion as described above with regard to the nerve root retractor, providing the same benefits of being able to tell if the contact between the instrument and the nerve is causing pathology degradation or if the procedure itself is helping to restore or improve the health or status of the peripheral nerve.

[0083] d. Virtual Patient for Evoked Potential Simulation

[0084] With reference to FIG. 16, the present invention also contemplates the use of a “virtual patient” device for simulating a naturally occurring recruitment curve. This is advantageous in that it provides the ability to test the various systems disclosed herein, which one would not be able to test without an animal and/or human subject. Based on the typically high costs of obtaining laboratory and/or surgical time (both in terms of human capital and overhead), eliminating the requirement of performing actual testing to obtain recruitment curves is a significant offering. According to the present invention, this can be accomplished by providing a device (not shown) having suitable software and/or hardware capable of producing the signal shown in FIG. 16. The device will preferably accept a sweeping current signal according to the present invention (that is, 200 microseconds width pulses sweeping in amplitude from 0-100 mA) and produce a voltage pulse having a peak-to-peak voltage (Vpp) that varies with the amplitude of the current input pulse. The relationship of the output Vpp and the input stimulation current will produce a recruitment curve similar to that shown. In one embodiment, the device includes various adjustments such that the features of the recruitment curve may be selectively modified. For example, the features capable of being modified may include, but are not necessarily limited to, Vpp at onset, maximum stimulation current of onselt (hanging point), the slope of the linear region and/or the Vpp of the saturation region.

[0085] While this invention has been described in terms of a best mode for achieving this invention's objectives, it will be appreciated by those skilled in the art that variations may be accomplished in view of these teachings without deviating from the spirit or scope of the present invention. For example, the present invention may be implemented using any combination of computer programming software, firmware or hardware. As a preparatory step to practicing the invention or constructing an apparatus according to the invention, the computer programming code (whether software or firmware) according to the invention will typically be stored in one or more machine readable storage mediums such as fixed (hard) drives, diskettes, optical disks, magnetic tape, semiconductor memories such as ROMs, PROMs, etc., thereby making an article of manufacture in accordance with the invention. The article of manufacture containing the computer programming code is used by either executing the code directly from the storage device, by copying the code from the storage device into another storage device such as a hard disk, RAM, etc. or by transmitting the code on a network for remote execution. As can be envisioned by one of skill in the art, many different combinations of the above may be used and accordingly the present invention is not limited by the scope of the appended claims.

Claims

What is claimed is:

1. A surgical system for stimulating nerves and monitoring EMG responses to the nerve simulation, comprising:

a control unit configured to receive user input regarding delivery of a stimulation signal and configured to receive neuromuscular response data, the control unit including a color display device and being configured to compute information for output to the color display device, said information being indicative of two or more of: nerve proximity, nerve direction, nerve pathology, stimulation level, EMG response data, pedicle integrity, advance or hold instructions, and instrument in use, wherein the color display device provides an evoked potentials display option that shows the voltage waveforms for a plurality of EMG response channels;

a connector module that comprises a plurality of EMG response channels and an electrical connection for at least one nerve stimulation instrument, the connector module having a wire connection to the control unit so that the connector module is positionable apart from the control unit;

a plurality of pairs of EMG electrodes connectable to the plurality of EMG response channels of the connector module, the EMG electrodes being mountable proximate to selected leg muscles;

a first stimulation instrument comprising a dilator tube and a stimulation element that delivers the stimulation signal proximate to a distal end of the dilator tube when the dilator tube is advanced through tissue in a path toward a spine; and

a second stimulation instrument comprising a pedicle probe that delivers the stimulation signal when advanced into a pedicle opening formed in the spine, wherein the pedicle probe comprises a probe tip member and handle with a user-actuatable button to activate the stimulation signal for delivery by the screw test probe.

2. The system of claim 1, further comprising one or more sequential dilator cannulas that are deliverable through the tissue in the path toward the spine.

3. The system of claim 1, further comprising an operative corridor instrument that is deliverable over the one or more sequential dilator cannulas when advanced toward the spine.

4. The system of claim 3, wherein the operative corridor instrument comprises a working cannula that defines a tubular corridor to access the spine when the working cannula is advanced to the spine.

5. The system of claim 1, wherein the stimulation element of the first stimulation instrument comprises an obturator arranged inside the dilator tube and equipped with one or more stimulation electrodes.

6. The system of claim 5, further comprising a guide wire that is insertable through the dilator tube when the obturator is removed from the dilator tube, the guide wire being insertable through the dilator tube and into an annulus of a disc of the spine.

7. The system of claim 5, wherein the connector module comprises eight EMG response channels.

8. The system of claim 7, wherein the plurality of pairs of EMG electrodes is eight pairs of EMG electrodes connectable to the eight EMG response channels.

9. The system of claim 8, further comprising an anode electrode to provide a return path for the stimulation signal and a common electrode.

10. The system of claim 1, wherein the control unit is configured to represent each of the plurality of EMG response channels on the color display device with a different color.

11. The system of claim 10, wherein the control unit is configured to indicate a preferred muscle location for each of the plurality of EMG electrodes on the color display device.

12. The system of claim 11, wherein the control unit is configured to indicate the preferred muscle location on the color display device using text associated with each channel.

13. The system of claim 11, wherein the control unit is configured to indicate the preferred muscle location on the color display device using an image of the human form.

14. The system of claim 10, wherein the control unit is configured to receive input of a selection of a channel tab associated with a specific EMG channel, and the control unit is configured to highlight on the color display device the preferred placement of the pair of EMG electrodes associated with the selected channel on an image of the human form and displays the name of the muscle monitored by the selected channel.

15. The system of claim 14, wherein the control unit is configured to output data for display on the color display device indicative of the spinal levels associated with the selected channel.

16. The system of claim 1, wherein the control unit further determines a relationship between stimulation signals and the neuromuscular response data to indicate at least one of nerve proximity, nerve direction, nerve pathology.

17. The system of claim 16, wherein the relationship determined is the threshold stimulation current required to evoke an EMG response greater than a predetermined minimum amplitude.

18. The system of claim 17, wherein the control unit automatically adjusts the magnitude of successive stimulation signals until the threshold stimulation current is determined.

19. The system of claim 18, wherein the control unit automatically adjusts the magnitude of successive stimulation signals by larger increments until a first bracket having a first width containing said threshold is determined, and thereafter automatically adjusts the magnitude of successive stimulation signals until a second bracket having a second width smaller than said first width and containing said stimulation threshold is determined.

20. The system of claim 19, wherein the predetermined minimum amplitude of the EMG response is 100 μV.

21. The system of claim 17, wherein the control unit is configured to output the value of the determined stimulation threshold for display on the color display device.

22. The system of claim 21, wherein the control unit displays a color determined by the threshold stimulation current determined.

23. The system of claim 22, wherein the control unit determines the threshold stimulation current for each of the plurality of EMG response channels.

24. The system of claim 23, wherein the control unit determines the threshold stimulation current on the EMG response channel having the lowest stimulation threshold current first.

25. The system of claim 1, wherein the color display comprises a touchscreen display.

26. The system of claim 25, wherein the touchscreen display is operable to receive user commands.

27. The system of claim 2, wherein at least one of the sequential dilator cannulas is connectable to the connector module and includes a stimulation element that delivers the stimulation signal proximate to a distal end of the at least one sequential dilator cannula when the at least one sequential dilator cannula is delivered through the tissue in the path toward the spine.

Patent Citations (290)

Patent	Date	Inventor	Cited By
US208227(A)	1878-09-01	Dorr	Applicant
US972983(A)	1910-10-01	Arthur	Applicant
US1328624(A)	1920-01-01	Graham	Applicant
US1548184(A)	1925-08-01	Cameron	Applicant
US2704064(A)	1955-06-01	Fizzell et al.	Applicant
US2736002(A)	1956-02-01	Oriel	Applicant
US2808826(A)	1957-10-01	Reiner et al.	Applicant
US3364929(A)	1968-01-01	Ide et al.	Applicant
US3664329(A)	1972-05-01	Naylor	Applicant
US3682162(A)	1972-08-01	Colyer	Applicant
US3785368(A)	1974-01-01	McCarthy et al.	Applicant
US3830226(A)	1974-08-01	Staub et al.	Applicant
US3957036(A)	1976-05-01	Normann	Applicant
US4099519(A)	1978-07-01	Warren	Applicant
US4164214(A)	1979-08-01	Stark et al.	Applicant
US4207897(A)	1980-06-01	Lloyd et al.	Applicant
US4224949(A)	1980-09-01	Scott et al.	Applicant
US4226228(A)	1980-10-01	Shin et al.	Applicant
US4235242(A)	1980-11-01	Howson et al.	Applicant
US4285347(A)	1981-08-01	Hess	Applicant
US4291705(A)	1981-09-01	Severinghaus et al.	Applicant
US4461300(A)	1984-07-01	Christensen	Applicant
US4515168(A)	1985-05-01	Chester et al.	Applicant
US4519403(A)	1985-05-01	Dickhudt	Applicant
US4545374(A)	1985-10-01	Jacobson	Applicant
US4561445(A)	1985-12-01	Berke et al.	Applicant
US4562832(A)	1986-01-01	Wilder et al.	Applicant
US4573448(A)	1986-03-01	Kambin	Applicant
US4592369(A)	1986-06-01	Davis et al.	Applicant
US4595018(A)	1986-06-01	Rantala	Applicant
US4611597(A)	1986-09-01	Kraus	Applicant
US4616660(A)	1986-10-01	Johns	Applicant
US4633889(A)	1987-01-01	Talalla	Applicant
US4658835(A)	1987-04-01	Pohndorf	Applicant
US4744371(A)	1988-05-01	Harris	Applicant
US4759377(A)	1988-07-01	Dykstra	Applicant
US4784150(A)	1988-11-01	Voorhies et al.	Applicant
US4807642(A)	1989-02-01	Brown	Applicant
US4892105(A)	1990-01-01	Prass	Applicant
US4913134(A)	1990-04-01	Luque	Applicant
US4926865(A)	1990-05-01	Oman	Applicant
US4962766(A)	1990-10-01	Herzon	Applicant
US4964411(A)	1990-10-01	Johnson et al.	Applicant
US5007902(A)	1991-04-01	Witt	Applicant
US5058602(A)	1991-10-01	Brody	Applicant
US5081990(A)	1992-01-01	Deletis	Applicant
US5092344(A)	1992-03-01	Lee	Applicant
US5125406(A)	1992-06-01	Goldstone et al.	Applicant
US5127403(A)	1992-07-01	Brownlee	Applicant
US5161533(A)	1992-11-01	Prass et al.	Applicant
US5171279(A)	1992-12-01	Mathews	Applicant
US5195541(A)	1993-03-01	Obenchain	Applicant
US5196015(A)	1993-03-01	Neubardt	Applicant
USRE34390(E)	1993-09-01	Culver	Applicant
US5255691(A)	1993-10-01	Otten	Applicant
US5282468(A)	1994-02-01	Klepinski	Applicant
US5284153(A)	1994-02-01	Raymond et al.	Applicant
US5284154(A)	1994-02-01	Raymond et al.	Applicant
US5295994(A)	1994-03-01	Bonutti	Applicant
US5299563(A)	1994-04-01	Seton	Applicant
US5312417(A)	1994-05-01	Wilk	Applicant
US5313956(A)	1994-05-01	Knutsson et al.	Applicant
US5313962(A)	1994-05-01	Obenchain	Applicant
US5327902(A)	1994-07-01	Lemmen	Applicant
US5331975(A)	1994-07-01	Bonutti	Applicant
US5333618(A)	1994-08-01	Lekhtman et al.	Applicant
US5342384(A)	1994-08-01	Sugarbaker	Applicant
US5375067(A)	1994-12-01	Berchin	Applicant
US5378241(A)	1995-01-01	Haindl	Applicant
US5383876(A)	1995-01-01	Nardella	Applicant
US5395317(A)	1995-03-01	Kambin	Applicant
US5450845(A)	1995-09-01	Axelgaard	Applicant
US5474558(A)	1995-12-01	Neubardt	Applicant
US5480440(A)	1996-01-01	Kambin	Applicant
US5482038(A)	1996-01-01	Ruff	Applicant
US5484437(A)	1996-01-01	Michelson	Applicant
US5509893(A)	1996-04-01	Pracas	Applicant
US5514153(A)	1996-05-01	Bonutti	Applicant
US5540235(A)	1996-07-01	Wilson	Applicant
US5549656(A)	1996-08-01	Reiss	Applicant
US5560372(A)	1996-10-01	Cory	Applicant
US5566678(A)	1996-10-01	Cadwell	Applicant
US5569248(A)	1996-10-01	Mathews	Applicant
US5571149(A)	1996-11-01	Liss et al.	Applicant
US5579781(A)	1996-12-01	Cooke	Applicant
US5593429(A)	1997-01-01	Ruff	Applicant
US5599279(A)	1997-02-01	Slotman et al.	Applicant
US5601608(A)	1997-02-01	Mouchawar	Applicant
US5630813(A)	1997-05-01	Kieturakis	Applicant
US5667508(A)	1997-09-01	Errico et al.	Applicant
US5671752(A)	1997-09-01	Sinderby et al.	Applicant
US5681265(A)	1997-10-01	Maeda et al.	Applicant
US5707359(A)	1998-01-01	Bufalini	Applicant
US5711307(A)	1998-01-01	Smits	Applicant
US5728046(A)	1998-03-01	Mayer et al.	Applicant
US5741253(A)	1998-04-01	Michelson	Applicant
US5759159(A)	1998-06-01	Masreliez	Applicant
US5762629(A)	1998-06-01	Kambin	Applicant
US5772661(A)	1998-06-01	Michelson	Applicant
US5775331(A)	1998-07-01	Raymond et al.	Applicant
US5776144(A)	1998-07-01	Leysieffer et al.	Applicant
US5779642(A)	1998-07-01	Nightengale	Applicant
US5785658(A)	1998-07-01	Benaron	Applicant
US5792044(A)	1998-08-01	Foley et al.	Applicant
US5797854(A)	1998-08-01	Hedgecock	Applicant
US5814073(A)	1998-09-01	Bonutti	Applicant
US5817071(A)	1998-10-01	Dewindt et al.	Applicant
US5830151(A)	1998-11-01	Hadzic et al.	Applicant
US5851191(A)	1998-12-01	Gozani	Applicant
US5853373(A)	1998-12-01	Griffith et al.	Applicant
US5860973(A)	1999-01-01	Michelson	Applicant
US5862314(A)	1999-01-01	Jeddeloh	Applicant
US5872314(A)	1999-02-01	Clinton	Applicant
US5885219(A)	1999-03-01	Nightengale	Applicant
US5888196(A)	1999-03-01	Bonutti	Applicant
US5902231(A)	1999-05-01	Foley et al.	Applicant
US5928139(A)	1999-07-01	Koros et al.	Applicant
US5928158(A)	1999-07-01	Aristides	Applicant
US5935131(A)	1999-08-01	Bonutti et al.	Applicant
US5938688(A)	1999-08-01	Schiff	Applicant
US5944658(A)	1999-08-01	Koros et al.	Applicant
US5976094(A)	1999-11-01	Gozani et al.	Applicant
US5976146(A)	1999-11-01	Ogawa et al.	Applicant
US6004262(A)	1999-12-01	Putz et al.	Applicant
US6004312(A)	1999-12-01	Finnerman	Applicant
US6007487(A)	1999-12-01	Foley et al.	Applicant
US6011985(A)	2000-01-01	Athan et al.	Applicant
US6027456(A)	2000-02-01	Feler et al.	Applicant
US6038469(A)	2000-03-01	Karlsson et al.	Applicant
US6038477(A)	2000-03-01	Kayyali	Applicant
US6050992(A)	2000-04-01	Nichols	Applicant
US6074343(A)	2000-06-01	Nathanson et al.	Applicant
US6095987(A)	2000-08-01	Schmulewitz	Applicant
US6104957(A)	2000-08-01	Alo et al.	Applicant
US6104960(A)	2000-08-01	Duysens et al.	Applicant
US6119068(A)	2000-09-01	Kannonji	Applicant
US6120503(A)	2000-09-01	Michelson	Applicant
US6126660(A)	2000-10-01	Dietz	Applicant
US6128576(A)	2000-10-01	Nishimoto	Applicant
US6132386(A)	2000-10-01	Gozani et al.	Applicant
US6132387(A)	2000-10-01	Gozani et al.	Applicant
US6135965(A)	2000-10-01	Tumer et al.	Applicant
US6139493(A)	2000-10-01	Koros et al.	Applicant
US6139545(A)	2000-10-01	Utley	Applicant
US6146335(A)	2000-11-01	Gozani	Applicant
US6146371(A)	2000-11-01	Dewindt et al.	Applicant
US6152871(A)	2000-11-01	Foley et al.	Applicant
US6161047(A)	2000-12-01	King et al.	Applicant
US6174311(B1)	2001-01-01	Branch et al.	Applicant
US6181961(B1)	2001-01-01	Prass	Applicant
US6196969(B1)	2001-03-01	Bester et al.	Applicant
US6206826(B1)	2001-03-01	Mathews et al.	Applicant
US6217509(B1)	2001-04-01	Foley et al.	Applicant
US6217527(B1)	2001-04-01	Selmon et al.	Applicant
US6221049(B1)	2001-04-01	Selmon et al.	Applicant
US6224549(B1)	2001-05-01	Drongelen	Applicant
US6231546(B1)	2001-05-01	Milo et al.	Applicant
US6259945(B1)	2001-07-01	Epstein et al.	Applicant
US6266558(B1)	2001-07-01	Gozani et al.	Applicant
US6270505(B1)	2001-08-01	Yoshida et al.	Applicant
US6273905(B1)	2001-08-01	Streeter	Applicant
US6292701(B1)	2001-09-01	Prass et al.	Applicant
US6306100(B1)	2001-10-01	Prass	Applicant
US6312392(B1)	2001-11-01	Herzon	Applicant
US6325764(B1)	2001-12-01	Griffith et al.	Applicant
US6334068(B1)	2001-12-01	Hacker	Applicant
US6348058(B1)	2002-02-01	Melkent et al.	Applicant
US6393325(B1)	2002-05-01	Mann et al.	Applicant
US6395007(B1)	2002-05-01	Bhatnagar et al.	Applicant
US6425859(B1)	2002-07-01	Foley et al.	Applicant
US6425901(B1)	2002-07-01	Zhu et al.	Applicant
US6447484(B1)	2002-09-01	Briscoe et al.	Applicant
US6451015(B1)	2002-09-01	Rittman, III et al.	Applicant
US6466817(B1)	2002-10-01	Kaula et al.	Applicant
US6468205(B1)	2002-10-01	Mollenauer et al.	Applicant
US6468207(B1)	2002-10-01	Fowler, Jr.	Applicant
US6500128(B2)	2002-12-01	Marino	Applicant
US6507755(B1)	2003-01-01	Turner et al.	Applicant
US6514217(B1)	2003-02-01	Selmon et al.	Applicant
US6520907(B1)	2003-02-01	Foley et al.	Applicant
US6524320(B2)	2003-02-01	DiPoto	Applicant
US6535759(B1)	2003-03-01	Epstein et al.	Applicant
US6564078(B1)	2003-05-01	Marino et al.	Applicant
US6579244(B2)	2003-06-01	Goodwin	Applicant
US6582441(B1)	2003-06-01	He et al.	Applicant
US6585638(B1)	2003-07-01	Yamamoto	Applicant
US6618626(B2)	2003-09-01	West et al.	Applicant
US6620157(B1)	2003-09-01	Dabney et al.	Applicant
US6641613(B2)	2003-11-01	Sennett	Applicant
US6645194(B2)	2003-11-01	Briscoe et al.	Applicant
US6679833(B2)	2004-01-01	Smith et al.	Applicant
US6719692(B2)	2004-04-01	Kleffner et al.	Applicant
US6760616(B2)	2004-07-01	Hoey et al.	Applicant
US6770074(B2)	2004-08-01	Michelson	Applicant
US6796985(B2)	2004-09-01	Bolger et al.	Applicant
US6810281(B2)	2004-10-01	Brock et al.	Applicant
US6819956(B2)	2004-11-01	DiLorenzo	Applicant
US6847849(B2)	2005-01-01	Mamo et al.	Applicant
US6849047(B2)	2005-02-01	Goodwin	Applicant
US6855105(B2)	2005-02-01	Jackson, III	Applicant
US6902569(B2)	2005-06-01	Parmer et al.	Applicant
US6916330(B2)	2005-07-01	Simonson	Applicant
US6926728(B2)	2005-08-01	Zucherman et al.	Applicant
US6929606(B2)	2005-08-01	Ritland	Applicant
US6945933(B2)	2005-09-01	Branch	Applicant
US7008431(B2)	2006-03-01	Simonson	Applicant
US7047082(B1)	2006-05-01	Schrom et al.	Applicant
US7050848(B2)	2006-05-01	Hoey et al.	Applicant
US7079883(B2)	2006-07-01	Marino et al.	Applicant
US7089059(B1)	2006-08-01	Pless	Applicant
US7177677(B2)	2007-02-01	Kaula et al.	Applicant
US7198598(B2)	2007-04-01	Smith et al.	Applicant
US7207949(B2)	2007-04-01	Miles et al.	Applicant
US7226451(B2)	2007-06-01	Shluzas et al.	Applicant
US7258688(B1)	2007-08-01	Shah et al.	Applicant
US7276055(B2)	2007-10-01	Dewindt et al.	Applicant
US7294127(B2)	2007-11-01	Leung et al.	Applicant
US7310546(B2)	2007-12-01	Prass	Applicant
US7311719(B2)	2007-12-01	Bonutti	Applicant
US7470236(B1)	2008-12-01	Kelleher et al.	Applicant
US7582058(B1)	2009-09-01	Miles et al.	Applicant
US2001/0039949(A1)	2001-11-01	Loubser	Applicant
US2001/0056280(A1)	2001-12-01	Underwood et al.	Applicant
US2002/0007129(A1)	2002-01-01	Marino	Applicant
US2002/0010392(A1)	2002-01-01	Desai	Applicant
US2002/0072686(A1)	2002-06-01	Hoey et al.	Applicant
US2002/0123780(A1)	2002-09-01	Grill et al.	Applicant
US2002/0161415(A1)	2002-10-01	Cohen et al.	Applicant
US2002/0193843(A1)	2002-12-01	Hill et al.	Applicant
US2003/0032966(A1)	2003-02-01	Foley et al.	Applicant
US2003/0078618(A1)	2003-04-01	Fey et al.	Applicant
US2003/0105503(A1)	2003-06-01	Marino	Applicant
US2003/0139648(A1)	2003-07-01	Foley et al.	Applicant
US2003/0149341(A1)	2003-08-01	Clifton	Applicant
US2003/0225405(A1)	2003-12-01	Weiner	Applicant
US2004/0181231(A1)	2004-09-01	Emstad et al.	Applicant
US2004/0199084(A1)	2004-10-01	Kelleher et al.	Applicant
US2004/0225228(A1)	2004-11-01	Ferree	Applicant
US2005/0004593(A1)	2005-01-01	Simonson	Applicant
US2005/0004623(A1)	2005-01-01	Miles et al.	Applicant
US2005/0033380(A1)	2005-02-01	Tanner et al.	Applicant
US2005/0075578(A1)	2005-04-01	Gharib et al.	Applicant
US2005/0080418(A1)	2005-04-01	Simonson et al.	Applicant
US2005/0119660(A1)	2005-06-01	Bourlion et al.	Applicant
US2005/0149035(A1)	2005-07-01	Pimenta et al.	Applicant
US2005/0182454(A1)	2005-08-01	Gharib et al.	Applicant
US2005/0192575(A1)	2005-09-01	Pacheco	Applicant
US2005/0256582(A1)	2005-11-01	Ferree	Applicant
US2006/0025703(A1)	2006-02-01	Miles et al.	Applicant
US2006/0052828(A1)	2006-03-01	Kim et al.	Applicant
US2006/0069315(A1)	2006-03-01	Miles et al.	Applicant
US2006/0224078(A1)	2006-10-01	Hoey et al.	Applicant
US2007/0016097(A1)	2007-01-01	Farquhar et al.	Applicant
US2007/0198062(A1)	2007-08-01	Miles et al.	Applicant
US2007/0293782(A1)	2007-12-01	Marino	Applicant
US2008/0015612(A1)	2008-01-01	Urmey	Applicant
US2008/0039914(A1)	2008-02-01	Cory et al.	Applicant
US2008/0058606(A1)	2008-03-01	Miles et al.	Applicant
US2008/0064976(A1)	2008-03-01	Kelleher et al.	Applicant
US2008/0064977(A1)	2008-03-01	Kelleher et al.	Applicant
US2008/0065178(A1)	2008-03-01	Kelleher et al.	Applicant
US2008/0071191(A1)	2008-03-01	Kelleher et al.	Applicant
US2008/0097164(A1)	2008-04-01	Miles et al.	Applicant
US2008/0300465(A1)	2008-12-01	Feigenwinter et al.	Applicant
US2009/0124860(A1)	2009-05-01	Miles et al.	Applicant
US2009/0138050(A1)	2009-05-01	Ferree	Applicant
US2009/0192403(A1)	2009-07-01	Gharib et al.	Applicant
US2009/0204016(A1)	2009-08-01	Gharib et al.	Applicant
DE29908259	1999-07-01		Applicant
EP759307	1997-02-01		Applicant
EP972538	2000-01-01		Applicant
FR2795624	2001-01-01		Applicant
FR2796846	2001-02-01		Applicant
JP11-076430	1999-03-01		Applicant
JP2001-170190	2001-06-01		Applicant
WO/38574	2000-07-01		Applicant
WO/62660	2000-10-01		Applicant
WO/66217	2000-11-01		Applicant
WO/67645	2000-11-01		Applicant
WO1/003604	2001-01-01		Applicant
WO1/37728	2001-05-01		Applicant
WO2/054960	2002-07-01		Applicant
WO3/005887	2003-01-01		Applicant
WO3/026482	2003-04-01		Applicant
WO3/037170	2003-05-01		Applicant
WO2004/012809	2004-02-01		Applicant
WO2005/013805	2005-02-01		Applicant
WO5/030318	2005-04-01		Applicant
WO6/042241	2006-04-01		Applicant
WO2006/066217	2006-06-01		Applicant

Non-Patent Literature (101)

“Electromyography System,” International Search report from International Application No. PCT/US00/32329, Apr. 27, 2001, 9 pages.Applicant
“Nerve Proximity and Status Detection System and Method,” International Search Report from International Application No. PCT/US01/18606, Oct. 18, 2001, 6 pages.Applicant
“Relative Nerve Movement and Status Detection System and Method,” International Search Report from International Application No. PCT/US01/18579, Jan. 15, 2002, 6 pages.Applicant
“System and Method for Determining Nerve Proximity Direction and Pathology During Surgery,” International Search Report from International Application No. PCT/US02/22247, Mar. 27, 2003, 4 pages.Applicant
“System and Methods for Determining Nerve Direction to a Surgical Instrument,” International Search Report from International Application No. PCT/US03/02056, Aug. 12, 2003, 5 pages.Applicant
“Systems and Methods for Performing Percutaneous pedicle Integrity Assessments,” International Search Report from International Application No. PCT/US02/35047, Aug. 11, 2003, 5 pages.Applicant
“Systems and Methods for Performing Surgery Procedures and Assessments,” International Search Report from International Application No. PCT/US02/30617, Jun. 5, 2003, 4 pages.Applicant
Lenke et al., “Triggered Electromyographic Threshold for Accuracy of Pedicle Screw Placement,” Spine, 1995, 20(4): 1585-1591.Applicant
“Brackmann II EMG System,” Medical Electronics, 1999, 4 pages.Applicant
“Neurovision SE Nerve Locator/Monitor”, RLN Systems Inc. Operators Manual, 1999, 22 pages.Applicant
“The Brackmann II EMG Monitoring System,” Medical Electronics Co. Operator's Manual Version 1.1, 1995, 50 pages.Applicant
“The Nicolet Viking IV,” Nicolet Biomedical Products, 1999, 6 pages.Applicant
Anderson et al., “Pedicle screws with high electrical resistance: a potential source of error with stimulus-evoked EMG,” Spine, Department of Orthopaedic Surgery University of Virginia, Jul. 15, 2002, 27(14): 1577-1581.Applicant
Bose et al., “Neurophysiologic Monitoring of Spinal Nerve Root Function During Instrumented Posterior Lumber Spine Surgery,” Spine, 2002, 27(13):1444-1450.Applicant
Calancie et al., “Stimulus-Evoked EMG Monitoring During Transpedicular Lumbosacral Spine Instrumentation” Spine, 1994, 19(24): 2780-2786.Applicant
Clements et al., “Evoked and Spontaneous Electromyography to Evaluate Lumbosacral Pedicle Screw Placement,” Spine, 1996, 21(5): 600-604.Applicant
Danesh-Clough et al. ,“The Use of Evoked EMG in Detecting Misplaced Thoracolumbar Pedicle Screws,” Spine, Orthopaedic Department Dunedin Hospital, Jun. 15, 2001, 26(12): 1313-1316.Applicant
Darden et al., “A Comparison of Impedance and Electromyogram Measurements in Detecting the Presence of Pedicle Wall Breakthrough,” Spine, Charlotte Spine Center North Carolina, Jan., 15, 1998, 23(2): 256-262.Applicant
Ebraheim et al., “Anatomic Relations Between the Lumbar Pedicle and the Adjacent Neural Structures,” Spine, Department of Orthopaedic Surgery Medical College of Ohio, Oct. 15, 1997, 22(20): 2338-2341.Applicant
Ford et al. “Electrical Characteristics of Peripheral Nerve Stimulators Implications for Nerve Localization,” Regional Anesthesia, 1984, 9: 73-77.Applicant
Glassman et al., “A Prospective Analysis of Intraoperative Electromyographic Monitoring of Pedicle Screw Placement With Computed Tomographic Scan Confirmation,” Spine, 1995, 20(12): 1375-1379.Applicant
Greenblatt et al., “Needle Nerve Stimulator-Locator: Nerve Blocks with a New Instrument for Locating Nerves,” Anesthesia& Analgesia, 1962, 41(5): 599-602.Applicant
Haig, “Point of view,” Spine, 2002, 27(24): 2819.Applicant
Haig et al., “The Relation Among Spinal Geometry on MRI, Paraspinal Electromyographic Abnormalities, and Age in Persons Referred for Electrodiagnostic Testing of Low Back Symptoms,” Spine, Department of Physical Medicine and Rehabilitation University of Michigan, Sep. 1, 2002, 27(17): 1918-1925.Applicant
Holland et al., “Higher Electrical Stimulus Intensities are Required to Activate Chronically Compressed Nerve Roots: Implications for Intraoperative Electromyographic Pedicle Screw Testing,” Spine, Department of Neurology, Johns Hopkins University School of Medicine, Jan. 15, 1998, 23(2): 224-227.Applicant
Holland, “Intraoperative Electromyography During Thoracolumbar Spinal Surgery,” Spine, 1998, 23(17): 1915-1922.Applicant
Journee et al., “System for Intra-Operative Monitoring of the Cortical Integrity of the Pedicle During Pedicle Screw Placement in Low-Back Surgery: Design and Clinical Results,” Sensory and Neuromuscular Diagnostic Instrumentation and Data Analysis I, 18th Annual International Conference on Engineering in Medicine and Biology Society, Amsterdam, 1996, pp. 144-145.Applicant
Maguire et al., “Evaluation of Intrapedicular Screw Position Using Intraoperative Evoked Electromyography,” Spine, 1995, 20(9): 1068-1074.Applicant
Martin et al. “Initiation of Erection and Semen Release by Rectal Probe Electrostimulation (RPE),” The Journal of Urology, The Williams& Wilkins Co., 1983, 129: 637-642.Applicant
Minahan et al., “The Effect of Neuromuscular Blockade on Pedicle Screw Stimulation Thresholds” Spine, Department of Neurology, Johns Hopkins University School of Medicine, Oct. 1, 2000, 25(19): 2526-2530.Applicant
Pither et al., “The Use of Peripheral Nerve Stimulators for Regional Anesthesia: Review of Experimental Characteristics Technique and Clinical Applications,” Regional Anesthesia, 1985, 10:49-58.Applicant
Raj et al., “Infraclavicular Brachial plexus Block—A New Approach” Anesthesia and Analgesia, 1973, (52)6: 897-904.Applicant
Raj et al., “The Use of Peripheral Nerve Stimulators for Regional Anesthesia,” Clinical Issues in Regional Anesthesia, 1985, 1(4):1-6.Applicant
Raj et al., “Use of the Nerve Stimulator for Peripheral Blocks,” Regional Anesthesia, Apr.-Jun.1980, pp. 14-21.Applicant
Raymond et al., “The Nerve Seeker: A System for Automated Nerve Localization,” Regional Anesthesia, 1992, 17(3): 151-162.Applicant
Shafik, “Cavernous Nerve Simulation through an Extrapelvic Subpubic Approach: Role in Penile Erection,” Eur. Urol, 1994, 26: 98-102.Applicant
Toleikis et al., “The Usefulness of Electrical Stimulation for Assessing Pedicle Screw Replacements,” Journal of Spinal Disorder, 2000, 13(4): 283-289.Applicant
Moed et al., “Insertion of an iliosacral implant in an animal model,” Journal of Bone and Joint Surgery, Nov .1999, 81A(11): 1529-1537.Applicant
“NIM-Response, so advanced . . . yet so simple,” XoMed, Inc., 1999, 12 pages.Applicant
Moed et al., “Intraoperative monitoring with stimulus-evoked electromyography during placement of iliosacral screws,” The Journal of Bone and Joint Surgery, Apr. 1998, 81A(4): 10 pages.Applicant
“New data analyzer combines the functions of six instruments in one unit” News Release, Nov. 11, 1987, 3 pages.Applicant
“NuVasive's spine surgery system cleared in the US,” Pharm & Medical Industry Week, Dec. 10, 2001, 1 page.Applicant
“Risk Capital Funds,” Innovation, Mar. 6, 1990, 172: 3 pages.Applicant
Anatomy of the Lumbar Spine in MED TM MicroEndoscopic Discectomy (1997 Ludann Grand Rapids MI), 14 pgs.Applicant
Dirksmeier et al., “Microendoscopic and Open Laminotomy and Discectomy in Lumbar Disc Disease” Seminars in Spine Surgery, 1999, 11(2): 138-146.Applicant
METRx Delivered Order Form, 1999, 13 pages.Applicant
Medtronic Sofamor Danek “METRx™ MicroDisectomy System,” Medtronic Sofamor Danek USA, 2000, 21 pgs.Applicant
Medtronic Sofamor Danek “METRx System Surgical Technique,” 2004, 22 pages.Applicant
“MetRx System MicroEndoscopic Discectomy: An Evolution in Minimally Invasive Spine Surgery,” Sofamor Danek, 1999, 6 pages.Applicant
Smith and Foley “MetRx System MicroEndoscopic Discectomy: Surgical Technique” Medtronic Sofamor Danek, 2000, 24 pages.Applicant
“Sofamor Danek MED Microendoscopic Discectomy System Brochure” including Rapp “New endoscopic lumbar technique improves access preserves tissue” Reprinted with permission from: Orthopedics Today, 1998, 18(1): 2 pages.Applicant
Japanese Patent Office JP Patent Application No. 2006-528306 Office Action with English Translation, Jun. 10, 2009, 4 pages.Applicant
Plaintiffs' Preliminary Invalidity Contentions re US Patents 7207949; 7470236 and 7582058, Sep. 18, 2009, 19 pages.Applicant
Plaintiffs' Preliminary Invalidity Contentions-Appendices, Sep. 18, 2009, 191 pages.Applicant
Plaintiffs' Supplemental Preliminary Invalidity Contentions re US Patents 7207949, 7470236, and 7582058, Sep. 29, 2009, 21 pages.Applicant
Plaintiffs' Supplemental Preliminary Invalidity Contentions-Appendices, Sep. 29, 2009, 294 pages.Applicant
Axon 501(k) Notification: Epoch 2000 Neurological Workstation, Dec. 3, 1997, 464 pages.Applicant
Foley and Smith, “Microendoscopic Discectomy,” Techniques in Neurosurgery, 1997, 3(4):301-307.Applicant
Medtronic Sofamor Danek “UNIION ™ /UNION-L™ Anterior & Lateral Impacted Fusion Devices: Clear choice of stabilization,” Medtronic Sofamor Danek, 2000, 4 pages.Applicant
NuVasive Vector™ Cannulae, 2000, 1 page.Applicant
NuVasive Triad™ Tri-Columnar Spinal EndoArthrodesis™ via Minimally Invasive Guidance, 2000, 1 page.Applicant
NuVasive Triad™ Cortical Bone Allograft, 2000, 1 page.Applicant
NuVasive Vertebral Body Access System, 2000, 1 page.Applicant
Marina, “New Technology for Guided Navigation with Real Time Nerve Surveillance for Minimally Invasive Spine Discectomy & Arthrodesis,” Spineline, 2000, p. 39.Applicant
NuVasive “INS-1 Screw Test,” 2001, 10 pages.Applicant
NuVasive letter re 510k Neuro Vision JJB System, Oct. 16, 2001, 5 pages.Applicant
NuVasive letter re 510k Guided Arthroscopy System, Oct. 5, 1999, 6 pages.Applicant
NuVasive letter re 510k INS-1 Intraoperative Nerve Surveillance System, Nov. 13, 2000, 7 pages.Applicant
“NuVasive™ Receives Clearance to Market Two Key Elem Minimally Invasive Spine Surgery System,” Nov. 27, 2001, 20 pages.Applicant
Schick et al., “Microendoscopic lumbar discectomy versus open surgery: an intraoperative EMG study,” Eur Spine J, 2002, 11: 20-26.Applicant
NuVasive letter re: 510(k) for Neurovision JJB System (Summary), Sep. 25, 2001, 28 pages.Applicant
NuVasive letter re: Special 510(k) Premarket Notification: Neurovision JJB System (Device Description), Jul. 3, 2003, 18 pages.Applicant
NuVasive letter re: Special 510(k) Premarket Notification: Neurovision JJB System (Device Description), Mar. 1, 2004, 16 pages.Applicant
NuVasive letter re: Special 510(k) Premarket Notification: Neurovision JJB System (Device Description), May 26, 2005, 17 pages.Applicant
NuVasive letter re: 510(k) Premarket Notification: Neurovision Jjb System (Device Description), Jun. 24, 2005, 16 pages.Applicant
NuVasive letter re: Special 510(k) Premarket Notification: Neurovision JJB System (Device Description), Sep. 14, 2006, 17 pages.Applicant
NuVasive 510(k) Premarket Notification: Neurovision JJB System (Device Description), Aug. 20, 2007, 8 pages.Applicant
NuVasive letter re: 510(k) Premarket Notification: Guided Spinal Arthroscopy System (Device Description), Feb. 1, 1999, 40 pages.Applicant
NuVasive 510(k) Premarket Notification: Spinal System (Summary), Apr. 12, 2004, 10 pages.Applicant
NuVasive 510(k) Summary NIM Monitor, Sep. 4, 1998, 4 pages.Applicant
NuVasive correspondence re 510(k) Premarket Notification INS-1 Intraoperative Nerve Surveillance System: Section IV Device Description, pp. 12-51 (prior to Sep. 25 2003).Applicant
Isley et al., “Recent Advances in Intraoperative Neuromonitoring of Spinal Cord Function: Pedicle Screw Stimulation Techniques,” American Journal of Electroneurodagnostic Technology, Jun. 1997, 37(2): 93-126.Applicant
Mathews et al., “Laparoscopic Discectomy with Anterior Lumbar Interbody Fusion,” SPINE, 1995, 20(16): 1797-1802.Applicant
Rose et al., “Persistently Electrified Pedicle Stimulation Instruments in Spinal Instrumentation: Techniques and Protocol Development,” SPINE, 1997, 22(3): 334-343.Applicant
Medtronic Sofamor Danek “UNION™ /UNION-L™ Anterior & Lateral Impacted Fusion Devices: Surgical Technique” Medtronic Sofamor Danek, 2001, 20 pages.Applicant
Defendant's Disclosure of Asserted Claims and Preliminary Infringement Contentions Regarding USP 7207949; 7470236 and 7582058, Aug. 31, 2009, 21 pages.Applicant
Bergey et al., “Endoscopic Lateral Transpsoas Approach to the Lumbar Spine,” Spine, 2004, 29(15): 1681-1688.Applicant
Dezawa et al., “Retroperitoneal Laparoscopic Lateral Approach to the Lumbar Spine: A New Approach, Technique, and Clinical Trial,” Journal of Spinal Disorders, 2000, 13(2): 138-143.Applicant
Gardocki, “Tubular diskectomy minimizes collateral damage: A logical progression moves spine surgery forward,” AAOS Now, 2009, 5 pages.Applicant
Hovorka et al., “Five years' experience of retroperitoneal lumbar and thoracolumbar surgery,” Eur. Spine J., 2000, 9(1): S30-S34.Applicant
Kossman et al., “The use of a retractor system (SynFrame) for open, minimal invasive reconstruction of the anterior column of the thoracic and lumbar spine,” Eur Spine J., 2001, 10: 396-402.Applicant
Mayer, “A New Microsurgical Technique for Minimally Invasive Anterior Lumbar Interbody Fusion,” Spine, 1997, 22(6): 691-699.Applicant
Mayer, “The ALIF Concept,” Eur Spine J., 2000, 9(1): S35-S43.Applicant
Mayer and Wiechert, “Microsurgical Anterior Approaches to the Lumbar Spine for Interbody Fusion and Total Disc Replacement,” Neurosurgery, 2002, 51(2): 159-165.Applicant
McAfee et al., “Minimally Invasive Anterior Retroperitoneal Approach to the Lumbar Spine: Emphasis on the Lateral BAK,” Spine, 1998, 23(13): 1476-1484.Applicant
Rao, et al. “Dynamic retraction of the psoas muscle to expose the lumbar spine using the retroperitoneal approach,” J. Neurosurg Spine, 2006, 5: 468-470.Applicant
Wolfla et al., “Retroperitoneal lateral lumbar interbody fusion with titanium threaded fusion cages,” J. Neurosurg (Spine 1), 2002, 96: 50-55.Applicant
Larson, Sanford J. et al., “Surgery of the Lumbar Spine,” 1999, pp. 305-319.Applicant
Medtronic Xomed Surgical Products, Inc. “NIM-Response Nerve Integrity Monitor Intraoperative EMG Monitor User's Guide, Revision B,” 2000.Applicant
Pimenta, Luiz. “Initial Clinical Results of Direct Lateral, Minimally Invasive Access to the Lumbar Spine for Disc Nucleus Replacement Using a Novel Neurophysiologica Monitoring System.” The 9th IMAST: May, 2002. 1 page.Applicant
“The Lateral Endoscopic Transpsoas Retroperitoneal Approach (Letra) for Implants in the Lumbar Spine” Second Interdisciplinary Congress on Spine Care World Spine II: Aug. 2003, 2 pages.Applicant